Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Robertson

Showing results (191-200 of 1,277) with videos related to

Pageof 128
Sort By:
Pigment Cell & Melanoma Research|July 4, 2015
Therapeutic interventions to disrupt the protein synthetic machinery in melanomaGregory R Kardos, Gavin P Robertson
Current Neurology and Neuroscience Reports|August 4, 2016
Alemtuzumab for Multiple SclerosisMark D Willis, Neil P Robertson
Journal of Neurology|July 4, 2013
Epidemiological aspects of Guillain-Barre syndromeDuncan J McLauchlan, Neil P Robertson
Journal of Neurology|April 3, 2016
Continuous evolution of magnetic resonance imaging in multiple sclerosisE C Tallantyre, N P Robertson
Journal of Neurology|October 8, 2020
Multiple sclerosis: early indicators of disease and assessing future riskM D Willis, N P Robertson
Radiography (London, England : 1995)|April 5, 2020
Radiotherapy without tattoos: Could this work?J Rigley, P Robertson, L Scattergood
Journal of Neurology|February 14, 2019
Technology-assisted recovery of walking after spinal cord injuryM D Willis, N P Robertson
Journal of Neurology|December 19, 2013
Risk and sub phenotype in Parkinson's diseaseR A Amin, N P Robertson
Journal of Neurology|March 30, 2017
Creutzfeldt-Jacob disease: new directions in diagnosis and therapeuticsAseel Al-Ansari, N P Robertson
The Journal of Clinical Investigation|November 1, 1978
Reversal by methysergide of inhibition of insulin secretion by prostaglandin E in the dogR P Robertson, R J Guest
Pageof 128

Showing results (191-200 of 1,277) with videos related to

Sort By:
Pageof 128
Pigment Cell & Melanoma Research|July 4, 2015
Therapeutic interventions to disrupt the protein synthetic machinery in melanomaGregory R Kardos, Gavin P Robertson
Current Neurology and Neuroscience Reports|August 4, 2016
Alemtuzumab for Multiple SclerosisMark D Willis, Neil P Robertson
Journal of Neurology|July 4, 2013
Epidemiological aspects of Guillain-Barre syndromeDuncan J McLauchlan, Neil P Robertson
Journal of Neurology|April 3, 2016
Continuous evolution of magnetic resonance imaging in multiple sclerosisE C Tallantyre, N P Robertson
Journal of Neurology|October 8, 2020
Multiple sclerosis: early indicators of disease and assessing future riskM D Willis, N P Robertson
Radiography (London, England : 1995)|April 5, 2020
Radiotherapy without tattoos: Could this work?J Rigley, P Robertson, L Scattergood
Journal of Neurology|February 14, 2019
Technology-assisted recovery of walking after spinal cord injuryM D Willis, N P Robertson
Journal of Neurology|December 19, 2013
Risk and sub phenotype in Parkinson's diseaseR A Amin, N P Robertson
Journal of Neurology|March 30, 2017
Creutzfeldt-Jacob disease: new directions in diagnosis and therapeuticsAseel Al-Ansari, N P Robertson
The Journal of Clinical Investigation|November 1, 1978
Reversal by methysergide of inhibition of insulin secretion by prostaglandin E in the dogR P Robertson, R J Guest
Pageof 128